Target- |
MechanismImmunostimulants |
|
|
|
Inactive Indication- |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc.AU |
First Approval Date20 Jan 2022 |
100 Clinical Results associated with Biocelect Pty Ltd
0 Patents (Medical) associated with Biocelect Pty Ltd
100 Deals associated with Biocelect Pty Ltd
100 Translational Medicine associated with Biocelect Pty Ltd